Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012;7(5):e36140.
doi: 10.1371/journal.pone.0036140. Epub 2012 May 3.

Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1

Affiliations
Meta-Analysis

Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1

Fuencisla Matesanz et al. PLoS One. 2012.

Abstract

Multiple Sclerosis (MS) is the most common progressive and disabling neurological condition affecting young adults in the world today. From a genetic point of view, MS is a complex disorder resulting from the combination of genetic and non-genetic factors. We aimed to identify previously unidentified loci conducting a new GWAS of Multiple Sclerosis (MS) in a sample of 296 MS cases and 801 controls from the Spanish population. Meta-analysis of our data in combination with previous GWAS was done. A total of 17 GWAS-significant SNPs, corresponding to three different loci were identified:HLA, IL2RA, and 5p13.1. All three have been previously reported as GWAS-significant. We confirmed our observation in 5p13.1 for rs9292777 using two additional independent Spanish samples to make a total of 4912 MS cases and 7498 controls (ORpooled = 0.84; 95%CI: 0.80-0.89; p = 1.36 × 10-9). This SNP differs from the one reported within this locus in a recent GWAS. Although it is unclear whether both signals are tapping the same genetic association, it seems clear that this locus plays an important role in the pathogenesis of MS.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: As a declaration of competing financial interest, several authors in this study (Dr. Gonzalez-Perez, Dr. Gayán, Dr. Moreno-Rey, Dr. Velasco, Dr. Real, and Dr. Ruiz) are employees and/or shareholders in Neocodex. The authors have also used publicly available data from a study that received funding from GSK. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Figures

Figure 1
Figure 1. Manhattan plot of Meta-Analysis of three GWAS datasets (Macarena, IMSGC/WT, GeneMSA).
Blue and red horizontal lines correspond to p values of 0.001 and 3.82×10-7 respectively.
Figure 2
Figure 2. Manhattan plot of Macarena GWAS.
Blue and red horizontal lines correspond to p values of 0.001 and 3.82×10-7 respectively.
Figure 3
Figure 3. Forest plot of Meta-analysis including the GWAS datasets (with GeneMSA included as three independent substudies), and the validation samples.
MAF: Minor Allele Frequency; US: United States; UK: United Kingdom; CH: Confoederatio Helvetica/Switzerland; HL: Holland.
Figure 4
Figure 4. Location of eQTLs of the 5p13.1 region and the SNPs associated to MS and Crohn diseases.
Image from the UCSC browser showing the chr5:39,840,547-40,924,217 (NCBI36/hg18) region. Vertical bars indicate the location of eQTLs and SNPs associated to Crohn or MS in different studies. eQTL PTGER4 are described by Zeller et al.; eQTL PTGER4 CEU are obtained from the correlation of PTGER4 expression in the CEU lymphoblastoid cell lines with the variants of the region; eQTL RPL37 are described by Stranger et al. and Dixon et al.; GWAS Crohn indicate the SNPs associated with the disease in different studies , , , ; GWAS MS indicate the SNPs associated with MS. LD plot performed with HapMap data from CEU population.

References

    1. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001;22:117–139. - PubMed
    1. Zuvich RL, McCauley JL, Pericak-Vance MA, Haines JL. Genetics and pathogenesis of multiple sclerosis. Semin Immunol. 2009;21:328–333. - PMC - PubMed
    1. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet. 2008;9:516–526. - PubMed
    1. Jersild C, Fog T, Hansen GS, Thomsen M, Svejgaard A, et al. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet. 1973;2:1221–1225. - PubMed
    1. Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol. 2007;61:228–236. - PMC - PubMed

Publication types